CXCR3 and CCR2 signaling leads to the recruitment of tumor-promoting immune cells, e.g., of TAMs, T cells and myeloid-derived suppressor cells (MDSC) [34,37,39,64]. The gene discussed is CCR2; the disease is neoplasm.